Wilmington’s Implant Sciences Lands Deal With Major French Airport

WILMINGTON, MA — Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced yesterday that the Company has received an order for 25 QS-B220 explosives trace detection systems from a major airport in France. The systems, which will be used to fulfill the recent European security regulations requirement for screening passengers and checked bags, are expected to be delivered in the Company’s fourth fiscal quarter, ending June 30, 2015.

“Our QS-B220 was selected for its superior performance in the airport operating environment. After conducting a long operational performance evaluation at the airport, the QS-B220’s performance was demonstrated to be far superior to the competition. This, along with the fact that the QS-B220 is the only non-rad ETD to have both the original STAC (France’s ETD approval) as well as the ECAC (European Civil Aviation Conference) qualification, drove the purchasing decision,” stated Dr. Darryl Jones, Implant Sciences’ Vice President of Global Sales and Marketing.  “We are very proud that Implant Sciences has won a number of procurements in head-to-head competition with our major competitors in Europe.  We are committed to providing the best technology and services to meet our clients’ needs in this demanding market.”

About the QS-B220 Desktop Explosives Trace Detector

The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives as well as illicit drugs. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.

About Implant Sciences

Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The Company’s team of dedicated trace detection experts has developed proprietary technologies used in its commercial products, thousands of which have been sold across more than 50 countries worldwide. The Company’s ETDs have received approvals and certifications from several international regulatory agencies including the TSA in the U.S., ECAC in Europe, CAAC and the Ministry of Public Safety in China, Russia FSB, STAC in France, and the German Ministry of the Interior. It has also received the GSN Homeland Security Award for “Best Explosives Detection Solution” two years in a row (2013 and 2014).  All Implant Sciences products are recognized as Qualified Anti-Terrorism Technologies by the Department of Homeland Security. For further details on the Company and its products, please visit the Company’s website at www.implantsciences.com.

(NOTE: Press release from Implant Sciences.)

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s